Delivery Order SPE2DB22D3301-SPE2DB24FY0EV
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,061.20 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract has a performance period through March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not designated as a set-aside contract. Amerisourcebergen Drug Corp also holds an...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The $6,795.87 contract has an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with the DLA, valued up to $999,999,999.00, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract, valued at $6,795.87, has an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and has a parent company, Cencora, Inc., which is also doing business as Amerisourcebergen. This delivery order...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML. The $4,530.60 order has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations. This award is likely part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The $6,795.87 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor. This award is part of a larger $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,530.60 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The award has an ultimate completion date of May 28, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products. The $4,530.60 delivery order is part of Amerisourcebergen's existing indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. The order does not have a set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,530.60 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a period of performance through October 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical commodities, including prescription medications,...
- The Defense Logistics Agency awarded a $11,717.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TEZSPIRE 210 mg/1.91 ml pen pharmaceutical products, with an ultimate completion date of October 9, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TEZSPIRE 210 MG/1.91 ML PEN (1.91ML) pharmaceutical product with a ceiling value of $2,343.59. This firm fixed-price delivery order, awarded on October 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and was...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY0EVDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products. The order has a potential value of $9,061.20 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the order was placed through DLA's primary indefinite delivery contract with the company, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. This contract does not have a set-aside designation and enables Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceuticals and medical supplies to support military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 2/6/24 |